Supervised contrastive learning framework for robust, fine-grained echocardiographic view classification across 47 clinically meaningful view types (rather than collapsing views into a few broad categories, as most prior work does). Introduces TTE47, the first publicly available benchmark with 47 fine-grained views independently annotated by three experts, enabling rigorous quantification of inter-observer agreement. A tailored contrastive loss produces a feature space that aligns more strongly with underlying anatomy than with any single annotator's labeling style, and the model outperforms cross-entropy and standard supervised-contrastive baselines on both TTE47 and the public TMED-2 benchmark (the latter without dataset-specific pretraining).

Prototype-based neural network for interpretable, uncertainty-aware classification of aortic stenosis (AS) severity from B-mode echocardiography videos. Rather than a black-box prediction, ProtoASNet bases its output on similarity scores between the input video and a set of learned spatio-temporal prototypes (typically highlighting valve calcification and restricted leaflet motion), and uses an abstention loss to flag ambiguous/uncertain cases for expert review. Evaluated on a private clinical dataset and the public TMED-2 dataset, it achieved balanced accuracy of 80.0% (private) and 79.7% (TMED-2), improving to 82.4% when uncertain cases are excluded.

Pediatric-specific extension of EchoNet-Dynamic: a video-based deep learning model that segments the left ventricle and estimates ejection fraction (EF) from apical-4-chamber (A4C) and parasternal short-axis (PSAX) pediatric echocardiogram clips. Because adult-trained echo models generalize poorly to children (who vary widely in heart size, rate, and image quality), EchoNet-Peds was trained from scratch on a dedicated pediatric video dataset. It segments the LV with a Dice similarity coefficient of 0.89 in both views, estimates EF with a mean absolute error of 3.66%, and identifies pediatric systolic dysfunction with an AUC of 0.95, significantly outperforming an adult-trained model applied to the same pediatric data.

Automated deep learning workflow that detects and grades tricuspid regurgitation (TR) severity from full transthoracic echocardiography studies. The pipeline first identifies apical-4-chamber (A4C) video clips with color Doppler across the tricuspid valve from a full echo study, then applies a dedicated R(2+1)D video classifier to grade TR severity. Trained on over 2 million echo videos from 47,312 studies at Cedars-Sinai Medical Center and externally validated at Stanford Healthcare, the model identified color-Doppler A4C views with AUC ≥0.999 and detected clinically significant (moderate-or-severe) TR with AUC 0.951 and severe TR with AUC 0.980. Code and trained model weights are released to support prospective evaluation of AI-assisted TR screening.

Video-based deep learning system for automated screening of rheumatic heart disease (RHD) from echocardiography, aimed at low-resource settings where RHD -- the most common acquired heart disease in children and young adults worldwide -- is endemic but echocardiography expertise is scarce. A 3D convolutional neural network (C3D) classifies each echo video clip, explicitly modeling temporal information across frames; a supervised meta-classifier then aggregates the per-video predictions from an exam (which may contain many video clips from different views) into a single exam-level RHD diagnosis. Evaluated on 11,646 echocardiography videos from 912 screening exams collected in underserved areas of Brazil and Uganda, the 3D C3D network significantly outperformed a comparison 2D CNN (VGG16) that ignores temporal information, and the learned aggregation model reached 72.77% exam-level diagnostic accuracy, exceeding simple majority voting across a patient's videos.

Multimodal machine learning model that flags patients at risk of transthyretin amyloid cardiomyopathy (ATTR-CM) -- a progressive, underdiagnosed disease with expanding disease-modifying treatment options -- from routinely available ECG waveforms, echocardiographic measurements, demographics, and diagnosis codes for orthopedic manifestations of amyloidosis (e.g. carpal tunnel syndrome, spinal stenosis). Developed on 799 patients with 5-fold cross-validation (AUROC 0.85) and externally validated on 422 patients at a separate site (AUROC 0.82), with consistent accuracy across Hispanic, non-Hispanic Black, and non-Hispanic White patients. In a subsequent nonrandomized, single-system, multisite clinical trial (the Cardiac Amyloidosis Discovery Trial), patients flagged by ATTRACTnet and referred for confirmatory amyloid scintigraphy were positive for ATTR-CM 48% of the time, more than 2.8x the positivity rate of historical (15.3%) and contemporary (17.0%) controls referred by usual clinical judgment (P < .001 for both). This is a proprietary clinical AI program; no public code or model weights have been released.

Multi-instance contrastive self-supervised learning framework for echocardiography video representation learning: two distinct videos from the same patient exam are treated as positive pairs (rather than augmentations of a single clip), and a frame-reordering pretext task on temporally shuffled frames encourages the 3D-CNN backbone to learn temporally coherent representations. After self-supervised pretraining on unlabeled echocardiograms, the backbone is efficiently fine-tuned for cardiac disease classification (severe aortic stenosis, left ventricular hypertrophy) using very few labeled examples, outperforming SimCLR, standard multi-instance SimCLR, and Kinetics-400-initialized baselines across a range of training-data ratios.

Predicts cardiac MRI (CMR) tissue-characterization findings -- wall-motion abnormalities and myocardial scar -- directly from standard transthoracic echocardiography videos (A4C/A2C/PLAX views), using a factorized 3D R2+1D convolutional network. Trained and validated on a single-institution cohort of more than 1,400 patients with paired echo and CMR studies within 30 days of each other. Released weights and inference code cover the two binarized outcomes (wall motion, scar); the continuous CMR tissue markers (native T1, T2, ECV) evaluated in the paper are not part of the public release.

Ensemble of 3D convolutional neural networks that detects severe aortic stenosis directly from single-view 2D parasternal long-axis (PLAX) transthoracic echocardiogram videos, without requiring Doppler imaging. Representations are first pretrained with patient-level contrastive self-supervised learning on PLAX clips, then fine-tuned for binary AS classification; the ensemble is externally validated across a temporally-distinct cohort and geographically-distinct cohorts in California and New England. No pretrained weights are released; only the training/evaluation pipeline is public.

Video-based deep learning model that grades aortic regurgitation (AR) severity—none/trace, mild, moderate, or severe—from color Doppler echocardiography. View-specific R(2+1)D 3D-CNNs analyze five standard transthoracic views (PLAX, PLAX-AV, A3C, A3C-AV, A5C) and their outputs are combined by a maximum-severity rule at the study level. Trained on ~47,600 color Doppler videos from Cedars-Sinai and externally validated at Stanford Healthcare, reaching AUCs of 0.95 for at-least-moderate AR and 0.97 for severe AR internally. Developed by the Ouyang lab at Cedars-Sinai Medical Center.

Open-source pipeline that classifies aortic stenosis (AS) severity from transthoracic echocardiography by combining structural and functional information. Video-based R(2+1)D convolutional networks read six B-mode and color Doppler views while a segmentation model measures peak aortic-jet velocity, and an ensemble integrates these into a final severity prediction. Trained on 210,193 images from Kaiser Permanente Northern California and validated across held-out, temporally distinct, and external Stanford and Cedars-Sinai cohorts, reaching AUCs up to 0.96–0.99 for severe AS. Developed by the Ouyang lab.

Video-based deep learning model that estimates 14 common blood biomarkers and laboratory values—including hemoglobin (anemia), B-type natriuretic peptide (BNP), troponin I, and blood urea nitrogen (BUN)—directly from apical-4-chamber echocardiogram videos. Built on a spatiotemporal convolutional network (R(2+1)D-style) with residual connections that produces beat-by-beat estimates for both regression and abnormality classification. Trained on over 70,000 echocardiograms from Stanford Healthcare and externally validated at Cedars-Sinai, reaching AUCs around 0.80–0.86 for detecting anemia and elevated BNP. Developed by the Ouyang and Zou labs at Stanford University and Cedars-Sinai.

Deep learning model for automated phenotyping of mitral stenosis (MS) from echocardiography. Uses video-based R(2+1)D convolutional networks on color Doppler and B-mode views to identify and grade mitral stenosis severity, following the multi-view valvular-assessment approach of the EchoNet family. Trained and validated on large clinical echocardiography cohorts from Kaiser Permanente Northern California with external testing at Stanford Healthcare and Cedars-Sinai. Developed by the Ouyang lab.

Echocardiography foundation model trained with a latent-predictive (V-JEPA2-style) self-supervised objective rather than pixel reconstruction, pretrained on 18 million echocardiograms from 300,000 patients drawn from the public MIMIC-IV-ECHO dataset plus a private multi-site archive - reportedly the largest echo pretraining corpus assembled to date. With a frozen backbone and only lightweight added layers, it outperforms prior echo foundation models by roughly 20% on ejection-fraction estimation and 17% on right-ventricular pressure estimation, reaches strong view-classification accuracy using just 1% of labels, and transfers zero-shot to pediatric echo better than fully fine-tuned baselines. Developed by the University of Toronto's Bo Wang Lab.

End-to-end pipeline for apical-4-chamber echocardiogram videos that segments the left ventricle, estimates ejection fraction on a beat-to-beat basis, and classifies cardiomyopathy with reduced ejection fraction. Combines a DeepLabV3-ResNet50 segmentation model with a 3D CNN (R2+1D/R3D/MC3) initialized on the Kinetics-400 video dataset. Trained on the public EchoNet-Dynamic dataset released alongside it, and one of the most widely reused open echocardiography models since its 2020 Nature publication. Developed by Stanford University.

Measures interventricular septum thickness, LV internal diameter, and posterior wall thickness from PLAX echocardiogram videos, then classifies the underlying cause of left ventricular hypertrophy as either cardiac amyloidosis or hypertrophic cardiomyopathy. Combines an atrous-convolution 2D CNN for wall-thickness segmentation with a 3D residual CNN for etiology classification. Trained on 28,201 videos across Stanford, Cedars-Sinai, and the Unity Imaging Collaborative. Developed by Stanford University.

Fully automated pipeline that scans a complete transthoracic echocardiogram study, identifies the apical-4-chamber color-Doppler clips showing the mitral valve, and grades mitral regurgitation severity at the study level. Combines a view/valve-presence classifier with a spatiotemporal CNN for severity classification. Trained on a private Cedars-Sinai cohort of 58,614 studies and externally validated on 915 studies from Stanford Healthcare.

View-agnostic, multi-task model that performs 39 different echocardiographic reporting tasks - covering chamber size and function, valve disease, and more - from any combination of views, aggregating clip-level predictions up to the study level. Combines a ConvNeXt-Tiny frame encoder with a temporal Transformer and separate output heads per task. Trained on private Yale-New Haven Health System echo videos and published in JAMA in 2025 by Yale's CarDS Lab.